La Guinée-Bissau suspend un essai clinique financé par les États-Unis alors que des scientifiques africains remettent en question ses motivations

Key Points

• The clinical trial suspension indicates serious concerns about motivation and ethical considerations.
• Key criticisms highlight the need for transparency in funded research and its implications on local communities.
• The research raises ethical questions regarding the oversight and intentions behind clinical trials in Africa.
• International scrutiny may result from the growing voice of African scientists in clinical research discussions.